We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current XPH market cap is 221.13M. The company's latest EPS is USD -0.9270 and P/E is -44.17.
Quarter End | |||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | |||||
Operating Income | |||||
Net Income |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 2.66M | 2.11M | 2.24M | 3.42M | 3.54M |
Operating Income | 0 | 0 | 0 | 0 | 0 |
Net Income | -24.68M | 16.95M | 46.43M | -42.2M | -5.01M |
Quarter End | |||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | |||||
Total Liabilities | |||||
Total Equity |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 216.55M | 253.63M | 288.58M | 211.12M | 229.91M |
Total Liabilities | 3.83M | 10.19M | 16.87M | 5.19M | 8.34M |
Total Equity | 212.72M | 243.44M | 271.72M | 205.93M | 221.57M |
Market Cap | 221.13M |
Price to Earnings Ratio | -44.17 |
Price to Sales Ratio | 62.56 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 1 |
Dividend Yield | - |
Shares Outstanding | 5.4M |
Average Volume (1 week) | 20.02k |
Average Volume (1 Month) | 27.85k |
52 Week Change | -3.10% |
52 Week High | 45.62 |
52 Week Low | 34.6704 |
Spread (Intraday) | 1.5 (3.6%) |
Company Name | SPDR S&P Pharmaceuticals |
Address |
one iron street boston, massachusetts 02210 |
Website | https://www.ssga.com |
Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions